Form 4: Elanco Animal Health Executive Grace McArdle Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


EVP Grace McArdle reports acquisition of restricted stock units and stock options, as well as disposition of shares to cover tax liabilities.

Summary

  • Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On March 1, 2024, McArdle was granted 14,193 restricted stock units (RSUs) under the 2018 Elanco Stock Plan.
  • These RSUs vest in three equal installments on March 1, 2025, March 1, 2026, and March 1, 2027.
  • Also on March 1, 2024, McArdle was granted stock options for 30,953 shares, vesting in the same manner as the RSUs.
  • McArdle disposed of 1,921 shares of common stock to cover tax liabilities associated with the vesting of previously awarded RSUs at a price of $16.03 per share.
  • Following these transactions, McArdle directly owns 54,908 shares of Elanco Animal Health Inc.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions, which is neutral in sentiment.

Positives

  • The grant of restricted stock units and stock options to an executive aligns their interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment to the company's success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

  • Stock option and RSU grants are a common form of executive compensation in the animal health and pharmaceutical industries.
  • Vesting schedules of three years are typical to incentivize long-term performance.
  • Companies like Zoetis and Merck Animal Health also utilize similar equity-based compensation plans for their executives.

Stakeholder Impact

  • The transactions have a minor impact on shareholders, providing transparency into executive compensation.
  • Employees may be impacted positively by the incentive structure of the stock options and RSUs.

Key Dates

DateDescription
03/01/2024Grant of restricted stock units and stock options, disposition of shares for tax liability.
03/01/2025First vesting date for one-third of the restricted stock units and stock options.
03/01/2026Second vesting date for one-third of the restricted stock units and stock options.
03/01/2027Final vesting date for the remaining restricted stock units and stock options.
03/05/2024Date of Form 4 filing.
03/01/2034Expiration date of the employee stock options.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.